Immunic | VTL - Net Income


Immunic reported $-19.3M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
BioMarin Pharmaceutical USD 44.76M 60.76M Jun/2026
Cipla INR 7.89B 2.34B Jun/2026
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -7.67M 64.51M Mar/2026
CSL USD 401M 96.5M Dec/2025
Enanta Pharmaceuticals USD -22.29M 93.76M Dec/2024
Grifols EUR 114.37M 34.03M Dec/2025
Immunic USD -19.3M 6.28M Dec/2025
Insmed USD -13.24M 150.32M Jun/2026
Omeros USD -32.23M 23.81M Sep/2024
OraSure Technologies USD -19.29M 5.57M Dec/2025
Quidel USD -92.9M 1.1M Jun/2026
Ultragenyx Pharmaceutical USD -185M 56M Mar/2026
United Therapeutics USD 333M 58.1M Jun/2026